About Us

Vetiqure AB is a subsidiary to Scandinavian ChemoTech AB, which is a R&D oriented publicly listed Life Science group with operations through subsidiaries and partners in Sweden, Europe, South East Asia, Middle East, India, Africa and USA. Vetiqure AB markets and sells vetIQure™, a product for the veterinary market, providing an efficient and flexible treatment of tumours with its Tumour Specific Electroporation™ technology, TSE. The vetIQure™ device is designed to effectively treat tumours and minimise destruction of the surrounding healthy cells. www.vetiqure.se

Subscribe